https://ift.tt/2IVHF6y

In August this year, Abraxis Biosciences LLC had alleged that SPARC's filing of NDA or Taclantis injection is an act of infringement of the Orange Book listed patents for Abraxane.

from Markets https://ift.tt/2RyI81v

Comments

Popular posts from this blog

IIT PhDs in demand for high-end R&D jobs

India Inc turn to non-bank routes for funding